• COVID Vaccine Protection Waning Against Infection -- but Not Hospitalization

    One study of 2-dose vaccination with Pfizer/BioNTech and Moderna mRNA vaccines found significantly diminishing efficacy against infection in nursing home residents, while two other studies showed sustained protection against coronavirus-related hospitalizations but declining coverage against new adult cases.

  • U.S. Early COVID-19 Vaccine Campaign Prevented Nearly 140,000 Deaths

    The early U.S. COVID-19 vaccination campaign prevented nearly 140,000 deaths and 3 million cases of COVID-19 by the second week of May, according to a new study. As a result of these early vaccination efforts, states experienced five fewer deaths from COVID-19 per 10,000 adult residents.

  • What the “Lyme Wars” Can Teach Us about COVID-19 and How to Find Common Ground in the School Reopening Debate

    As schools reopen, concerns over a delta-driven surge in cases, vaccine ineligibility for children younger than 12 and varying opinions about mask use in school settings loom large.The Lyme controversy offers four lessons on how parents, school districts, elected officials and scientists can find common ground – and a path forward – in the 2021-2022 school year.

  • Focusing on Zoonotic Diseases

    Experts warn that zoonotic diseases—diseases caused by germs that spread from animals to people—are a growing and increasingly dangerous threat to global public health. Veterinarian and PNNL data scientist Lauren Charles talks animal-borne diseases—and how biosurveillance can help combat them

  • Debate over Origins of COVID-19 Continues

    At the end of the month, the U.S. intelligence community (IC) will submit a report to President Joe Biden offering the IC’s conclusions regarding the origins of COVID-1. The report is not likely to put an end to the debate, especially since China is refusing access to key materials and personnel.

  • Parasites Fight Chemical and Biological Weapons

    Harnessing parasites to help soldiers and first responders counter chemical and biological weapon attacks in war zones.

  • Medicine Manufacturing Limits Poses Risk to U.S. Health Security

    More than 80 percent of the active ingredients in medicines the U.S. Food and Drug Administration deems essential for public health have no U.S. manufacturing source. Essential medicines include antibiotics, antivirals, blood pressure pills, steroids and many others. This vulnerability of the U.S. public health care system is not only matter of health care security, but of national security as well.

  • How Have Communities Been Faring During COVID-19? And How Will Lessons Learned Inform Future Response and Planning?

    Now may be a good time to examine the choices communities made during the last year to see how these approaches shape continued COVID-19 response and recovery and help build resilience for future pandemic response.

  • Studies Look at COVID-19 Vaccines-Connected Clotting, Myocarditis

    Two studies published by JAMA Cardiology Tuesday discuss adverse effects associated with COVID-19 vaccines. Despite these risks, both research teams continue to advocate for COVID-19 vaccines as the health risks from the virus are far greater than those linked to the vaccine.

  • Path Towards a Global Pathogen Early Warning System

    The world’s ability to detect, track, and analyze disease threats has improved considerably over the past several decades, the COVID-19 pandemic drove home a terrible reality: the systems we had in place are still deeply insufficient for halting the rapid spread of a novel pathogen fast enough to prevent a staggering level of damage. 

  • Model Predicts COVID-19 Outbreak Two Weeks Ahead of Time

    People’s social behavior, reflected in their mobility data, is providing scientists with a way to forecast the spread of COVID-19 nationwide at the county level. The data-driven deep learning model which FAU researchers developed has important implications for managing the current pandemic as well as future pandemics.

  • First Case of Marburg Virus Infection Detected in Guinea

    The deadly Marburg disease has claimed its first victim in Guinea. The disease has been reported in Africa before, but the infection in Guinea is the first time the disease has been reported in West Africa. The Marburg virus is part of the Ebola family. In 2014-2015, tens of thousands died in Guinea, Sierra Leon, and Liberia from a rampaging Ebola outbreak.

  • Members of Scientific Journal Editorial Board Resign over China Genetics Papers

    Eight members of the editorial board of Molecular Genetics & Genomic Medicine have resigned after the journal published several controversial papers which “critics fear could be used for DNA profiling and persecution of ethnic minorities in China.”

  • Global Warming Increased U.S. Crop Insurance Losses by $27 Billion in 27 Years

    Higher temperatures attributed to climate change caused payouts from the nation’s biggest farm support program to increase by $27 billion between 1991 and 2017, according to new estimates from Stanford researchers. Costs are likely to rise even further with the growing intensity and frequency of heat waves and other severe weather events.

  • Virus Likely Naturally Occurring: NIH

    The NIH says that based on the scientific literature, its view is that “SARS-CoV-2 infection in people most likely resulted from zoonotic transmission from animals to humans.” Current evidence does not support the assertion that the virus was engineered, but the NIH does not rule out the possibility of a laboratory accident, in which a naturally occurring virus was unintentionally released during research activities.